Posts

Showing posts with the label scoliscore

ScoliScore (TM) - Axial Biotech

Axial Biotech declared some news today via PRNewswire, I would like to share that with you. I don´t have much to say about this as I am no Dr!, however, Wow - I have been reading about DNA tests being linked to treatment for Scoliosis and disease progression but now it looks like we are really rocking! I look forward to following Axial in their developments of DNA. Axial Biotech Announces Commercial Availability of SCOLISCORE(TM) AIS Prognostic Test The first marketed product of Axial's pipeline of personalized diagnostics for spine disorders SALT LAKE CITY, Sept. 24 /PRNewswire/ -- Axial Biotech, Inc., a company personalizing spine care through the development of molecular diagnostics, announced today that its SCOLISCORE(TM) AIS Prognostic Test is now being made available to spine specialists in the United States. SCOLISCORE is a saliva-based genetic test designed to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine. Spine surgeons from 40 m...

Axial Biotech Wins 2009 Award

Axial Biotech Wins 2009 Innovation Award for Biotechnology Company recognized from more than 100 companies for innovative technology SALT LAKE CITY, May 4 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostic technologies, was selected as the winner at the 9th Annual Utah Innovation Award Ceremony. The award recognizes significant innovations and the companies that created them. The Utah Technology Council and Stoel Rives, LLP presented the award to Axial Biotech during an awards ceremony held Thursday, April 30, 2009. Axial Biotech's award winning product, ScoliScore(TM), is the first-ever genetic test for patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). This new molecular diagnostic tool marks a major advancement in which medical treatments can be personalized to patients diagnosed with this deforming disease. ScoliScore(TM) was developed by utilizing a genome wide association study that identified ...